KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Exchange Rate Effect: 2015-2025

Historic Exchange Rate Effect for CRISPR Therapeutics AG (CRSP) over the last 10 years, with Sep 2025 value amounting to -$27,000.

  • CRISPR Therapeutics AG's Exchange Rate Effect fell 136.00% to -$27,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $7,000, marking a year-over-year decrease of 94.49%. This contributed to the annual value of -$21,000 for FY2024, which is 128.77% down from last year.
  • According to the latest figures from Q3 2025, CRISPR Therapeutics AG's Exchange Rate Effect is -$27,000, which was down 133.75% from $80,000 recorded in Q2 2025.
  • CRISPR Therapeutics AG's 5-year Exchange Rate Effect high stood at $115,000 for Q4 2022, and its period low was -$100,000 during Q3 2022.
  • Moreover, its 3-year median value for Exchange Rate Effect was $28,000 (2023), whereas its average is $13,273.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first slumped by 1,460.00% in 2022, then spiked by 3,900.00% in 2025.
  • CRISPR Therapeutics AG's Exchange Rate Effect (Quarterly) stood at $3,000 in 2021, then surged by 3,733.33% to $115,000 in 2022, then tumbled by 46.96% to $61,000 in 2023, then plummeted by 242.62% to -$87,000 in 2024, then plummeted by 136.00% to -$27,000 in 2025.
  • Its Exchange Rate Effect stands at -$27,000 for Q3 2025, versus $80,000 for Q2 2025 and $41,000 for Q1 2025.